1. Home
  2. STOK vs MSEX Comparison

STOK vs MSEX Comparison

Compare STOK & MSEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • MSEX
  • Stock Information
  • Founded
  • STOK 2014
  • MSEX 1897
  • Country
  • STOK United States
  • MSEX United States
  • Employees
  • STOK N/A
  • MSEX N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • MSEX Water Supply
  • Sector
  • STOK Health Care
  • MSEX Utilities
  • Exchange
  • STOK Nasdaq
  • MSEX Nasdaq
  • Market Cap
  • STOK 997.9M
  • MSEX 933.6M
  • IPO Year
  • STOK 2019
  • MSEX N/A
  • Fundamental
  • Price
  • STOK $19.76
  • MSEX $53.54
  • Analyst Decision
  • STOK Strong Buy
  • MSEX Buy
  • Analyst Count
  • STOK 6
  • MSEX 4
  • Target Price
  • STOK $26.60
  • MSEX $61.00
  • AVG Volume (30 Days)
  • STOK 920.7K
  • MSEX 111.5K
  • Earning Date
  • STOK 08-12-2025
  • MSEX 07-31-2025
  • Dividend Yield
  • STOK N/A
  • MSEX 2.54%
  • EPS Growth
  • STOK N/A
  • MSEX 17.05
  • EPS
  • STOK 0.91
  • MSEX 2.41
  • Revenue
  • STOK $199,893,000.00
  • MSEX $195,831,000.00
  • Revenue This Year
  • STOK $415.58
  • MSEX $5.46
  • Revenue Next Year
  • STOK N/A
  • MSEX $8.74
  • P/E Ratio
  • STOK $21.55
  • MSEX $22.15
  • Revenue Growth
  • STOK 1218.82
  • MSEX 11.91
  • 52 Week Low
  • STOK $5.35
  • MSEX $48.18
  • 52 Week High
  • STOK $20.00
  • MSEX $70.73
  • Technical
  • Relative Strength Index (RSI)
  • STOK 78.62
  • MSEX 50.35
  • Support Level
  • STOK $19.07
  • MSEX $52.83
  • Resistance Level
  • STOK $19.91
  • MSEX $54.16
  • Average True Range (ATR)
  • STOK 1.26
  • MSEX 1.10
  • MACD
  • STOK 0.14
  • MSEX 0.15
  • Stochastic Oscillator
  • STOK 96.55
  • MSEX 59.64

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About MSEX Middlesex Water Company

Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.

Share on Social Networks: